SEC Filings TLDR

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.

2025-10-27SCHEDULE 13G/A
2025-10-27WOLFSCHEDULE 13G/AFMR LLC Increases Stake in Wolfspeed Inc. to 10.6%+10.60%MEDIUM
FMR LLC has filed a Schedule 13G/A amendment, disclosing an increased ownership of 10.6% in Wolfspeed Inc. The filing indicates that FMR LLC now holds 2,737,652 shares of Wolfspeed's common stock, valued at approximately $84,566,070.28. The shares are held in the ordinary course of business and not for the purpose of i...
2025-10-27SCHEDULE 13G/A
2025-10-27SCHEDULE 13G/ASumitomo Mitsui Trust Group and Amova Asset Management's 13G/A Filing for Schrodinger, Inc.MEDIUM
Sumitomo Mitsui Trust Group, Inc. and Amova Asset Management Co., Ltd. have filed an amendment to their Schedule 13G, reporting their beneficial ownership of 7.1% of Schrodinger, Inc.'s common stock, totaling 4,554,569 shares. Both entities are classified as parent holding companies and non-U.S. institutions. The share...
2025-10-27SCHEDULE 13G/ASumitomo Mitsui Trust Group and Amova Asset Management Co. Report 7.2% Ownership in Arcturus Therapeutics Holdings Inc.MEDIUM
Sumitomo Mitsui Trust Group, Inc. and Amova Asset Management Co., Ltd. have filed a Schedule 13G/A amendment reporting a 7.2% ownership in Arcturus Therapeutics Holdings Inc. The filing indicates that both entities, classified as parent holding companies and non-U.S. institutions, beneficially own 1,947,835 shares of c...
2025-10-27SCHEDULE 13G/ASumitomo Mitsui Trust Group and Amova Asset Management Report 4.7% Ownership in 10x GenomicsLOW
Sumitomo Mitsui Trust Group, Inc. and Amova Asset Management Co., Ltd. have filed a Schedule 13G/A amendment reporting a 4.7% ownership in 10x Genomics, Inc. The filing indicates that the shares are held in the ordinary course of business and not for the purpose of influencing control of the issuer. Sumitomo Mitsui Tru...
2025-10-27SYSCHEDULE 13G/AAmendment No. 4 to Schedule 13G for So-Young International Inc.MEDIUM
This Amendment No. 4 to Schedule 13G, filed by MPC III L.P., MPC III-A L.P., MPC Management III L.P., MPC GPGP III Ltd., MPC III HK Limited, and David Su, updates the beneficial ownership of Class A ordinary shares of So-Young International Inc. The Reporting Persons collectively own 6.8% of the outstanding Class A ord...
2025-10-27SDGRSCHEDULE 13G/ASumitomo Mitsui Trust Group and Amova Asset Management Co., Ltd. Report 7.1% Ownership in Schrodinger, Inc.MEDIUM
Sumitomo Mitsui Trust Group, Inc. and Amova Asset Management Co., Ltd. have filed a Schedule 13G/A amendment reporting a 7.1% ownership in Schrodinger, Inc. The filing indicates that both entities, classified as parent holding companies and non-U.S. institutions, beneficially own 4,554,569 shares of Schrodinger's commo...
2025-10-27SCHEDULE 13G/A
2025-10-27SCHEDULE 13G/A
2025-10-27SCHEDULE 13G/A
2025-10-27LARSCHEDULE 13G/AAmendment to Schedule 13G Filing by Ganfeng Lithium Group Co., Ltd.LOW
Ganfeng Lithium Group Co., Ltd. has filed an amendment to its Schedule 13G to correct the form type from Schedule 13G to Schedule 13G/A. The amendment reflects ownership of 15,810,000 common shares of Lithium Argentina AG as of June 30, 2025. The original filing on October 16, 2025, was inadvertently filed as Schedule ...
2025-10-27SCHEDULE 13G/A
2025-10-27SCHEDULE 13G/A
2025-10-27SCHEDULE 13G/AFMR LLC's Schedule 13G/A Filing for Wolfspeed Inc.MEDIUM
FMR LLC filed an amendment to its Schedule 13G for Wolfspeed Inc., disclosing ownership of 2,737,652 shares of common stock, representing 10.6% of the total outstanding shares. The filing indicates that FMR LLC has sole voting power over 2,659,126 shares and sole dispositive power over all 2,737,652 shares. The filing ...
2025-10-27ARCTSCHEDULE 13G/ASumitomo Mitsui, Amova Report 7.2% Stake in Arcturus TherapeuticsMEDIUM
Sumitomo Mitsui Trust Group, Inc. and Amova Asset Management Co., Ltd. have filed a Schedule 13G/A amendment reporting their beneficial ownership of 7.2% of the common stock of Arcturus Therapeutics Holdings Inc. The filing indicates that both entities, classified as parent holding companies, non-U.S. institutions, and...
2025-10-27KRKRSCHEDULE 13G/AAmendment No. 3 to Schedule 13G for 36Kr Holdings Inc.LOW
This filing is Amendment No. 3 to the Schedule 13G originally filed by Tembusu Limited and David Su Tuong Sing on December 21, 2019, and previously amended on February 14, 2023, and November 15, 2025. The amendment updates the beneficial ownership of Class A Ordinary Shares of 36Kr Holdings Inc. Tembusu Limited and Dav...
2025-10-27TXGSCHEDULE 13G/ASumitomo Mitsui Trust Group and Amova Asset Management's 13G/A Filing for 10x GenomicsLOW
Sumitomo Mitsui Trust Group, Inc. and Amova Asset Management Co., Ltd. have filed an amended Schedule 13G/A with the SEC, reporting their beneficial ownership of Class A common stock in 10x Genomics, Inc. The filing indicates that Sumitomo Mitsui Trust Group, Inc. and Amova Asset Management Co., Ltd. collectively own a...
2025-10-27IPWSCHEDULE 13GWhite Cherry Limited and Xinbo Du's Ownership in iPower Inc.MEDIUM
White Cherry Limited and Xinbo Du have filed a Schedule 13G indicating their ownership in iPower Inc. White Cherry Limited, a British Virgin Islands company, and Xinbo Du, its sole member, collectively own 3,083,700 shares of iPower Inc.'s common stock, representing 9.8% of the total shares. The filing certifies that t...
2025-10-27XRTXSCHEDULE 13GLincoln Alternative Strategies LLC Reports 9.9% Ownership in XORTX Therapeutics Inc.MEDIUM
Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, reporting beneficial ownership of 572,470 common shares of XORTX Therapeutics Inc., representing 9.9% of the outstanding shares. The filing indicates that the shares were not acquired for the purpose of influencing the control of the issuer. Linc...
2025-10-27SCHEDULE 13G
2025-10-27SCHEDULE 13G
2025-10-27TRINZSCHEDULE 13GTrinity Capital Inc. Reports 17% Ownership in Eagle Point Trinity Senior Secured Lending CompanyMEDIUM
Trinity Capital Inc. has filed a Schedule 13G with the SEC, disclosing a 17% ownership stake in Eagle Point Trinity Senior Secured Lending Company. Trinity Capital Inc. holds 1,002,204 common shares of beneficial interest, with sole voting and dispositive power over these shares. The filing indicates that Trinity Capit...
2025-10-27SCHEDULE 13GSumitomo Mitsui Trust Group and Amova Asset Management Report 5.7% Stake in Nextdoor HoldingsMEDIUM
Sumitomo Mitsui Trust Group, Inc. and Amova Asset Management Co., Ltd. have filed a Schedule 13G reporting a 5.7% beneficial ownership in Nextdoor Holdings, Inc. The filing indicates that the two entities collectively own 13,660,830 shares of Class A common stock. Both companies are classified as parent holding compani...
2025-10-27SCHEDULE 13GSumitomo Mitsui Trust Group and Amova Asset Management Report 5.1% Ownership in Ibotta, Inc.MEDIUM
Sumitomo Mitsui Trust Group, Inc. and Amova Asset Management Co., Ltd. have filed a Schedule 13G reporting a 5.1% ownership in Ibotta, Inc. The filing indicates that both entities, classified as parent holding companies, beneficially own 1,279,895 and 1,279,655 shares of Class A Common Stock, respectively. The securiti...
Previous Page123456Next Page